SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 124 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,024,183 | -19.4% | 70,536 | +16.1% | 0.04% | -20.8% |
| Q2 2023 | $1,271,351 | +17.1% | 60,743 | +18.1% | 0.05% | +6.7% |
| Q1 2023 | $1,086,096 | +53.2% | 51,425 | +26.0% | 0.04% | +60.7% |
| Q1 2022 | $709,000 | +39.0% | 40,804 | +75.1% | 0.03% | +21.7% |
| Q4 2021 | $510,000 | +78.9% | 23,298 | +40.3% | 0.02% | +27.8% |
| Q2 2021 | $285,000 | -45.5% | 16,609 | -28.9% | 0.02% | -30.8% |
| Q1 2021 | $523,000 | +32.1% | 23,368 | +31.2% | 0.03% | +52.9% |
| Q4 2020 | $396,000 | – | 17,816 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |